Related Experiment Video
Updated: Mar 26, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Trichosporon fungemia in a pediatric patient with acute lymphoblastic leukemia
Luke Maxfield1, Juliana J Matthews1, David Ryan Ambrosetti1
15151 N. Ninth Avenue, Pensacola, FL 32504, United States.
Abstract:
Trichosporon fungemia is a life-threatening opportunistic infection that is increasing in frequency. Invasive disease occurs almost exclusively in immunocompromised hosts, particularly in neutropenic adults with hematological malignancies and uncommonly in children. We report the case of a pediatric patient where disseminated trichosporonosis progressed while on micafungin, between treatments with voriconazole and amphotericin B, demonstrating the difficulty with and importance of prolonged and continuous treatment.
Insights
Trichosporon fungemia is a dangerous infection in immunocompromised patients. This case highlights the challenges in treating pediatric trichosporonosis, emphasizing the need for continuous antifungal therapy.
Area of Science:
- Mycology
- Infectious Diseases
- Pediatric Medicine
Background:
- Trichosporon fungemia is an opportunistic infection with increasing incidence.
- Invasive disease predominantly affects immunocompromised individuals, especially neutropenic adults with hematological malignancies.
- Pediatric cases are uncommon but can be severe.
Purpose of the Study:
- To report a case of disseminated trichosporonosis in a pediatric patient.
- To illustrate the therapeutic challenges and the importance of sustained antifungal treatment in pediatric trichosporonosis.
Main Methods:
- Case report of a pediatric patient with disseminated trichosporonosis.
- Documented treatment course including micafungin, voriconazole, and amphotericin B.
- Clinical and microbiological monitoring during antifungal therapy.
Main Results:
- Disseminated trichosporonosis progressed despite treatment with micafungin.
- The patient received sequential antifungal agents, including voriconazole and amphotericin B.
- Treatment failure indicated the complexity of managing this infection in a pediatric host.
Conclusions:
- Pediatric trichosporonosis can be difficult to treat and may progress during antifungal therapy.
- Prolonged and continuous antifungal treatment is crucial for successful outcomes.
- This case underscores the need for careful monitoring and adaptable treatment strategies for invasive fungal infections in children.
More Related Videos
08:01Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Fungal Phylum Microsporidia
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...